ENP Newswire -
Release date- 22052014 -
The financing was underwritten by
The Underwriters purchased, on a 'bought deal' basis by way of a short form prospectus, 32,400,000 common shares of the Company (the 'Shares') at a price of
The net proceeds are intended to be used for the Company's commissioning and development activities and ongoing financial obligations related to its
RBI is a Canadian company formed pursuant to the arrangement involving
Certain information contained in this news release, including any information relating to the use of proceeds and statements regarding our ability and the timing to achieve and sustain commercial production and name-plate production levels of iodine are 'forward-looking statements'. These forward-looking statements relate to future events or future performance and reflect the Company's expectations regarding the future growth, results of operations, business prospects and opportunities of RBI.
These forward-looking statements also reflect the Company's current internal projections, expectations or beliefs and are based on information currently available to the Company. In some cases forward-looking information can be identified by terminology such as 'may', 'will', 'should', 'expect', 'intend', 'plan', 'anticipate', 'believe', 'estimate', 'projects', 'potential', 'scheduled', 'forecast', 'budget' or the negative of those terms or other comparable terminology.
The estimates and assumptions of RBI underlying the forward-looking statements in this news release may prove to be incorrect.
Assumptions upon which such forward looking information include, among other things, successful and timely commissioning, ramp-up and production at the
Although the Company believes that the forward-looking information contained in this news release is based on reasonable assumptions, readers cannot be assured that actual results will be consistent with such statements. Accordingly, readers are cautioned against placing undue reliance on forward-looking information. RBI expressly disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, events or otherwise, except in accordance with applicable securities laws.
Tel: 604 689 7842
Fax: 604 689 4250
Most Popular Stories
- Islamic State Obliterating Cultural Landmarks in Mosul
- The 2014 Fastest-Growing 100
- 'Lucy's' Super Powers Tops 'Hercules' at Box Office
- Boehner Says Impeachment Talk Is Democrat Scam
- You're So Vain: Microsoft to Launch First 'Selfie Phone'
- U.S. Home Price Gains Slow for 6th Month in a Row
- VW Site Could Mean Another 2,000 Jobs for Chattanooga
- RV Sales See Highest Increase Post Great Recession
- Merck Profit More Than Doubles in Q2
- Report: China to Declare Qualcomm a Monopoly